Cardiometabolic disorders and weight: A complex constellation of interrelated conditions

Article

This constellation of conditions-cardiometabolic disorders and weight-has become one of the most pressing public health issues today, affecting approximately a quarter of the U.S. population, accounting for a substantial proportion of health-care and prescription drug spending, and threatening the vitality of an aging population.

Key Points

An estimated 47 million Americans have double the average risk of heart disease because they are affected by a complex constellation of interrelated conditions, including obesity, impaired glucose metabolism, hypertension, and lipid disorders.1 These patients also are five times more likely to develop diabetes, according to the National Heart, Lung, and Blood Institute.1

This constellation of conditions-cardiometabolic disorders and weight (CMDW)-has become one of the most pressing public health issues today, affecting approximately a quarter of the U.S. population, accounting for a substantial proportion of health-care and prescription drug spending, and threatening the vitality of an aging population.1,2

Obesity

Recent research indicates that excess visceral adipose tissue releases metabolites, cytokines, chemokines, and hormones that influence inflammation and other factors to affect atherogenesis and the vessel wall directly.6

In an effort to slow the obesity epidemic, 19 states have set stricter nutritional standards for school meals, 27 states have nutritional standards for foods sold in schools, and 20 now require body mass index screening or other weight assessment of schoolchildren.7

Impaired glucose metabolism

In the United States, 17.9 million patients have diagnosed diabetes; an estimated 5.7 million cases remain undiagnosed, and an additional 57 million people have prediabetes, according to the American Diabetes Association.8 The incidence of diabetes among those aged 60 years or more is 23.1%. An estimated 16.5% of the adult American Indian and Alaska native population are affected by diabetes.8 After adjusting for age differences, the prevalence of diabetes is 11.8% among non-Hispanic blacks, 10.4% among Hispanic Americans, 7.5% in Asian Americans, and 6.6% among non-Hispanic whites.8

Overall, approximately 210,000 Americans aged more than 20 years have diabetes, an incidence of 0.26%, but the data do not differentiate between diabetes types.8 Type 2 diabetes, however, is being diagnosed more frequently in children, especially among Native Americans and African and Hispanic Americans. In addition, one in six overweight adolescents-approximately 2 million-have prediabetes.8

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.